Literature DB >> 27859486

Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders.

Timothy P Rutkowski1, Jason P Schroeder1, Georgette M Gafford1, Stephen T Warren1, David Weinshenker1, Tamara Caspary1, Jennifer G Mulle1,2.   

Abstract

Recent studies show that the complex genetic architecture of schizophrenia (SZ) is driven in part by polygenic components, or the cumulative effect of variants of small effect in many genes, as well as rare single-locus variants with large effect sizes. Here we discuss genetic aberrations known as copy number variants (CNVs), which fall in the latter category and are associated with a high risk for SZ and other neuropsychiatric disorders. We briefly review recurrent CNVs associated with SZ, and then highlight one CNV in particular, a recurrent 1.6-Mb deletion on chromosome 3q29, which is estimated to confer a 40-fold increased risk for SZ. Additionally, we describe the use of genetic mouse models, behavioral tools, and patient-derived induced pluripotent stem cells as a means to study CNVs in the hope of gaining mechanistic insight into their respective disorders. Taken together, the genomic data connecting CNVs with a multitude of human neuropsychiatric disease, our current technical ability to model such chromosomal anomalies in mouse, and the existence of precise behavioral measures of endophenotypes argue that the time is ripe for systematic dissection of the genetic mechanisms underlying such disease.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CNVs; CRISPR; behavioral assays; genetics; schizophrenia

Mesh:

Year:  2016        PMID: 27859486      PMCID: PMC5352473          DOI: 10.1002/jnr.23970

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  183 in total

1.  Doc2alpha is an activity-dependent modulator of excitatory synaptic transmission.

Authors:  G Sakaguchi; T Manabe; K Kobayashi; S Orita; T Sasaki; A Naito; M Maeda; H Igarashi; G Katsuura; H Nishioka; A Mizoguchi; S Itohara; T Takahashi; Y Takai
Journal:  Eur J Neurosci       Date:  1999-12       Impact factor: 3.386

Review 2.  Animal models of neuropsychiatric disorders.

Authors:  Eric J Nestler; Steven E Hyman
Journal:  Nat Neurosci       Date:  2010-09-27       Impact factor: 24.884

Review 3.  Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.

Authors:  Shengdar Q Tsai; J Keith Joung
Journal:  Nat Rev Genet       Date:  2016-05       Impact factor: 53.242

Review 4.  Endonucleases: new tools to edit the mouse genome.

Authors:  Tobias Wijshake; Darren J Baker; Bart van de Sluis
Journal:  Biochim Biophys Acta       Date:  2014-04-30

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

6.  Overlap of autistic and schizotypal traits in adolescents with Autism Spectrum Disorders.

Authors:  Petra S Barneveld; Jolijn Pieterse; Leo de Sonneville; Sophie van Rijn; Bertine Lahuis; Herman van Engeland; Hanna Swaab
Journal:  Schizophr Res       Date:  2010-10-08       Impact factor: 4.939

7.  Schizophrenia patients demonstrate a dissociation on declarative and non-declarative memory tests.

Authors:  W Perry; G A Light; H Davis; D L Braff
Journal:  Schizophr Res       Date:  2000-12-15       Impact factor: 4.939

8.  Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark.

Authors:  S S Kety; P H Wender; B Jacobsen; L J Ingraham; L Jansson; B Faber; D K Kinney
Journal:  Arch Gen Psychiatry       Date:  1994-06

9.  Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid human cell line.

Authors:  Patrick Essletzbichler; Tomasz Konopka; Federica Santoro; Doris Chen; Bianca V Gapp; Robert Kralovics; Thijn R Brummelkamp; Sebastian M B Nijman; Tilmann Bürckstümmer
Journal:  Genome Res       Date:  2014-11-04       Impact factor: 9.043

10.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

View more
  11 in total

1.  Systems Analysis of the 22q11.2 Microdeletion Syndrome Converges on a Mitochondrial Interactome Necessary for Synapse Function and Behavior.

Authors:  Avanti Gokhale; Cortnie Hartwig; Amanda A H Freeman; Julia L Bassell; Stephanie A Zlatic; Christie Sapp Savas; Trishna Vadlamudi; Farida Abudulai; Tyler T Pham; Amanda Crocker; Erica Werner; Zhexing Wen; Gabriela M Repetto; Joseph A Gogos; Steven M Claypool; Jennifer K Forsyth; Carrie E Bearden; Jill Glausier; David A Lewis; Nicholas T Seyfried; Jennifer Q Kwong; Victor Faundez
Journal:  J Neurosci       Date:  2019-03-04       Impact factor: 6.167

2.  NCBP2 modulates neurodevelopmental defects of the 3q29 deletion in Drosophila and Xenopus laevis models.

Authors:  Mayanglambam Dhruba Singh; Matthew Jensen; Micaela Lasser; Emily Huber; Tanzeen Yusuff; Lucilla Pizzo; Brian Lifschutz; Inshya Desai; Alexis Kubina; Sneha Yennawar; Sydney Kim; Janani Iyer; Diego E Rincon-Limas; Laura Anne Lowery; Santhosh Girirajan
Journal:  PLoS Genet       Date:  2020-02-13       Impact factor: 5.917

3.  A Schizophrenia-Linked KALRN Coding Variant Alters Neuron Morphology, Protein Function, and Transcript Stability.

Authors:  Theron A Russell; Melanie J Grubisha; Christine L Remmers; Seok Kyu Kang; Marc P Forrest; Katharine R Smith; Katherine J Kopeikina; Ruoqi Gao; Robert A Sweet; Peter Penzes
Journal:  Biol Psychiatry       Date:  2017-11-07       Impact factor: 13.382

4.  Editorial overview: Rare CNV disorders and neuropsychiatric phenotypes: opportunities, challenges, solutions.

Authors:  Jennifer Gladys Mulle; Patrick F Sullivan; Jens Hjerling-Leffler
Journal:  Curr Opin Genet Dev       Date:  2021-05-28       Impact factor: 5.578

Review 5.  The association between gene variants and longitudinal structural brain changes in psychosis: a systematic review of longitudinal neuroimaging genetics studies.

Authors:  Julia H Harari; Covadonga M Díaz-Caneja; Joost Janssen; Kenia Martínez; Bárbara Arias; Celso Arango
Journal:  NPJ Schizophr       Date:  2017-11-01

6.  Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.

Authors:  Masayuki Baba; Kazumasa Yokoyama; Kaoru Seiriki; Yuichiro Naka; Kensuke Matsumura; Momoka Kondo; Kana Yamamoto; Misuzu Hayashida; Atsushi Kasai; Yukio Ago; Kazuki Nagayasu; Atsuko Hayata-Takano; Akinori Takahashi; Shun Yamaguchi; Daisuke Mori; Norio Ozaki; Tadashi Yamamoto; Kazuhiro Takuma; Ryota Hashimoto; Hitoshi Hashimoto; Takanobu Nakazawa
Journal:  Neuropsychopharmacology       Date:  2019-06-19       Impact factor: 7.853

7.  Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders.

Authors:  Grazia Rutigliano; Riccardo Zucchi
Journal:  Cell Mol Neurobiol       Date:  2019-10-23       Impact factor: 5.046

8.  Mitochondrial Proteostasis Requires Genes Encoded in a Neurodevelopmental Syndrome Locus.

Authors:  Avanti Gokhale; Chelsea E Lee; Stephanie A Zlatic; Amanda A H Freeman; Nicole Shearing; Cortnie Hartwig; Oluwaseun Ogunbona; Julia L Bassell; Meghan E Wynne; Erica Werner; Chongchong Xu; Zhexing Wen; Duc Duong; Nicholas T Seyfried; Carrie E Bearden; Viktor János Oláh; Matthew J M Rowan; Jill R Glausier; David A Lewis; Victor Faundez
Journal:  J Neurosci       Date:  2021-07-14       Impact factor: 6.167

Review 9.  A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.

Authors:  Alessia Casamassa; Daniela Ferrari; Maurizio Gelati; Massimo Carella; Angelo Luigi Vescovi; Jessica Rosati
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

10.  In Vitro Modeling of the Bipolar Disorder and Schizophrenia Using Patient-Derived Induced Pluripotent Stem Cells with Copy Number Variations of PCDH15 and RELN.

Authors:  Takaya Ishii; Mitsuru Ishikawa; Koki Fujimori; Takuji Maeda; Itaru Kushima; Yuko Arioka; Daisuke Mori; Yuhki Nakatake; Bun Yamagata; Shintaro Nio; Takahiro A Kato; Nan Yang; Marius Wernig; Shigenobu Kanba; Masaru Mimura; Norio Ozaki; Hideyuki Okano
Journal:  eNeuro       Date:  2019-10-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.